Magic Mushrooms could lengthen your lifespan
Scientists at the university's department of medicine in Atlanta discovered that psilocybin increased cellular longevity and enhanced survival rates in aged mice.
The study, published last week in the journal Nature, defined Psilocybin as the "naturally occurring psychedelic compound produced by hallucinogenic mushrooms.'
Researchers noted growing interest in psilocybin for treating psychiatric and neurodegenerative conditions, but this study offers the first experimental evidence that psilocin, its active form, boosts longevity in aged mice.
The study suggests psilocybin may be a powerful anti-aging agent, with data showing it reduces oxidative stress, prevents DNA damage and helps preserve telomere length, which all help slow the aging process.
The older white-haired mice even appeared younger after treatment, regrowing black hair.
"Psilocybin appears to slow the 'wear and tear' that accompanies aging," co-author of the study, Louise Hecker of Emory University, told Fox News Digital. "Mice and cells are healthier and live significantly longer."
While the study suggests this could also work for humans, much more testing is needed. Hecker told the outlet that researchers need to answer questions such as, "What are the optimal dosing protocols for humans? What is the optimal age for treatment initiation for optimal benefits?"
"Is there an age, beyond which point, when treatment does not provide efficacy?' she continued. 'Are there potential harms or adverse effects associated with long-term treatment? What are the mechanisms of its action? All these questions need to be rigorously tested."
Gabe Charambides, founder of the U.S.' first legal psilocybin retreat in Oregon, called the findings 'compelling' but stressed that human use requires stricter screening, preparation and safety than in mice.
He added that those who may benefit most from psilocybin therapy are people feeling 'stuck' after major life events, such as childhood trauma, divorce, job loss or bereavement, or those seeking to improve their mental health.
Charambides said his retreat guests have reported relief from physical issues such as chronic pain and migraines, though no biological testing is conducted.
Ryan Moss of Filament Health, a Canadian clinical-stage natural psychedelic drug development company, previously stressed to Fox News Digital that the use of psychedelics should be administered in a safe, controlled setting.
"Psychedelic experiences can sometimes feature anxiety, hallucinations, and paranoia," Moss said. "Some patients using traditional psychedelics have reported experiencing adverse cardiovascular events during clinical trials."
He recommends that clinical trial participants be well-prepared and closely monitored by trained professionals.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Independent
23 minutes ago
- The Independent
Ousted vaccine panel members say rigorous science is being abandoned
The 17 experts who were ousted from a government vaccine committee last month say they have little faith in what the panel has become, and have outlined possible alternative ways to make U.S. vaccine policy. U.S. Health Secretary Robert F. Kennedy Jr. abruptly fired the entire Advisory Committee on Immunization Practices, accusing them of being too closely aligned with manufacturers and of rubber-stamping vaccines. He handpicked replacements that include several vaccine skeptics. In a commentary published Wednesday in the New England Journal of Medicine, the former panel members wrote that Kennedy — a leading voice in the anti-vaccine movement before becoming the U.S. government's top health official — and his new panel are abandoning rigorous scientific review and open deliberation. That was clear, they said, during the new panel's first meeting, in June. It featured a presentation by an anti-vaccine advocate that warned of dangers about a preservative used in a few flu vaccines, but the committee members didn't hear from Centers for Disease Control and Prevention staffers about an analysis that concluded there was no link between the preservative and neurodevelopmental disorders. The new panel recommended that the preservative, thimerosal, be removed even as some members acknowledged there was no proof it was causing harm. 'That meeting was a travesty, honestly,' said former ACIP member Dr. Yvonne Maldonado, a pediatric infectious diseases expert at Stanford University. The 17 discharged experts last month published a shorter essay in the Journal of the American Medical Association that decried Kennedy's 'destabilizing decisions." The focus was largely on their termination and on Kennedy's decision in May to stop recommending COVID-19 vaccines for healthy children and pregnant women. In the new commentary, the ousted committee members took it one step further and prescribed some steps that could be taken to maintain scientifically sound vaccine recommendations. 'An alternative to the Committee should be established quickly and — if necessary — independently from the federal government," they wrote. 'No viable pathway exists to fully replace the prior trusted and unbiased ACIP structure and process. Instead, the alternatives must focus on limiting the damage to vaccination policy in the United States.' Options included having professional organizations working together to harmonize vaccine recommendations or establishing an external auditor of ACIP recommendations. There are huge challenges to the ideas, including having access to the best data, the authors acknowledged. There's also the question of whether health insurers would pay for vaccinations that are recommended by alternative groups but not ACIP. They might pick and choose which vaccines to cover, said the University of North Carolina 's Noel Brewer, another former ACIP member. For example, they might pay for vaccines that offer more immediate cost savings for health care, like the flu vaccine. 'But maybe not ones that have a longer-term benefit like HPV vaccine,' which is designed to prevent futures cancers, Brewer said. Officials with the U.S. Department of Health and Human Services did not immediately respond to a request for comment. ___ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Science and Educational Media Group and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.
The Independent
23 minutes ago
- The Independent
Senate committee passes bill that aims to stop sharks stealing fish from anglers
A Senate committee voted Wednesday to pass a bill that aims to stop sharks from biting fish on fishing lines. The so-called SHARKED Act will create a task force to study shark behavior and make recommendations accordingly. The vote before the U.S. Senate Committee on Commerce, Science, and Transportation was passed by voice Wednesday morning. The task force will have to report back within two years on improving coordination and communication across the fisheries management and shark research communities, and develop strategies to address shark depredation, which is defined as the partial or complete removal of a hooked fish by a shark directly from a fishing line. However, wildlife advocacy groups say the bill 'falls short by not explicitly forbidding the task force from proposing shark culls or population reductions as a solution,' which would leave the door open to killing sharks. 'While it can be frustrating to have a shark bite your catch while fishing, shark populations are in trouble. Globally, sharks have declined by 71 percent since 1970, primarily due to overfishing,' the group said in a statement. Earth Justice highlights that factors including overfishing of sharks by industrial as well as human-caused climate change and pollution has proved devastating to populations. 'While certain shark populations are beginning to recover, it's crucial to remember the principle of shifting baselines,' said Jasmin Graham, President and CEO of Minorities in Shark Sciences. 'Even though there may be more sharks than in recent history, we're still far below historic levels.' According to an online summary of the bill, the duties of the task force are to develop ways to improve coordination and communication across the fisheries management and shark research communities, as well as identifying research priorities and funding opportunities. It will also develop recommended management strategies to address shark depredation and coordinate the development and distribution of educational materials. The bill specifies that the task force must include representatives of each Regional Fishery Management Council, each Marine Fisheries Commission, the fish and wildlife agencies of coastal states, and the National Marine Fisheries Service. The task force must also include 'researchers and others with relevant expertise,' but does not specify who such others may be. Earth Justice says that this 'fails to include representation from Indigenous, tribal and native people, even though sharks are considered sacred to some, according to Earth Justice. The task force must report its findings to Congress within two years after the bill's enactment and every two years thereafter until the task force is terminated. 'Depredation is a complex issue, one that reflects the health of our ocean ecosystems as a whole,' adds Graham. 'As fish populations decline, both sharks and fishers are competing for the same limited resources. 'Sharks are becoming habituated to areas with fishing boats, chum, and bait, while increasingly effective fishing gear is putting pressure on the system and increasing the possibility of interactions. As we address this issue, we must tread carefully. 'We must ensure that our efforts to address shark depredation don't undo the progress we've made or ignore the deeper, underlying causes of these challenges.'
Reuters
24 minutes ago
- Reuters
Brown University reaches deal with US government to restore federal funding
WASHINGTON, July 30 (Reuters) - Brown University said on Wednesday it reached a voluntary agreement with the U.S. government to restore funding for the university's federally sponsored medical and health sciences research and to resolve some compliance reviews.
